Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.25, read 2026-10-28
Ethical passes the values gate
Price116.09 USD
Fair value111.68
Ethical score70.0/100
Our investment reviews on this name
2026-10-11Read Markup99.36+16.8% to today ✓Distribution gives way to Markup first Markup read since August
2026-09-15Read Distribution97.35+19.3% to today Markup gives way to Distribution first Distribution read since July
2026-08-15Read Markup100.15+15.9% to today ✓Distribution gives way to Markup after a 23% rise in 6 weeks
2026-07-02Read Distribution81.41+42.6% to today First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Thomson-Reuters Corp holds its Markup at $116.09. Consolidating, no directional conviction, held for 1 days.
As held on the ledger · 2026-10-28
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 1 days
Price at the screen
$116.09
Valuation
28.41 trailing · 21.35 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.20
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
13.22%
Below 33%
Interest-bearing debt is just 13.2% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.99%
Below 33%
Cash held in interest-bearing accounts and securities is 1.0% of assets, under the one-third limit.
Pass
Receivables
8.26%
Below 49%
Money owed to the company is 8.3% of assets, under the 49% limit.
Pass
Revenue purity
0.54%
Below 5%
Only 0.5% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Thomson-Reuters clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 13%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when TRI's ethical verdict changes
Today TRI passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Conscience Overlay
Conscience flag · AFSC Investigate
The quantitative screen above is arithmetic and this name passes it. Separately, community boycott lists cite this company: Documented on AFSC Investigate. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
Fair value range in USD, drawn from the 2026-10-28 screen. The gold marker is the market price at the same screen. The price runs 3.8% above the base estimate.
Third-party analyst targets: 12 covering, consensus Buy. The average target sits +5% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-28 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Trusted research tools but no real edge
Lawyers and accountants still reach for familiar platforms when they need verified data fast. Thomson Reuters delivers that service across legal, tax and news segments, with revenue rising 10 percent and margins holding at 20 percent. Yet the narrow moat and opportunity rating of none leave us with little reason to step in.
The forward multiple sits at 19.1 times earnings while return on equity runs at just 13 percent. A 15 percent margin of safety to fair value exists on paper, and the ethical screen clears, but the business shows no standout quality that would justify stretching for it now.
Currency moves, competition from newer platforms and modest returns on capital all sit in the risk column. The setup looks steady rather than compelling. Analysis, not advice.
The risks · The things to watch: its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
TRI trades on NASDAQ (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-25Markup$108.23+0.3%Entry 9
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it buy, with a mean price target of $123.
2026-10-18Markup$107.89+8.6%Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 8.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it buy, with a mean price target of $123.
2026-10-11Markup · changed$99.36+0.0%Entry 7
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it buy, with a mean price target of $123.
2026-10-02Distribution$99.36+2.1%Entry 6
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 2.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it buy, with a mean price target of $123.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it buy, with a mean price target of $123.
2026-08-15Markup · changed$100.15+23.0%Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 23.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it buy, with a mean price target of $123.
2026-07-18Distribution$81.41+0.0%Entry 3
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 56%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it buy, with a mean price target of $123.
2026-07-03Distribution$81.41+0.0%Entry 2
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Distribution$81.41Entry 1
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
